Covered recipient · General Payments record
TAYLOR N MEDLEY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$1,317.02
- Reported across 88 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $553.08 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $171.70 | 12 |
| Novo Nordisk AS | $140.24 | 10 |
| Lilly USA, LLC | $47.96 | 3 |
| Merck Sharp & Dohme Corporation | $43.29 | 2 |
| Astellas Pharma US Inc | $34.28 | 2 |
| SANOFI-AVENTIS U.S. LLC | $21.28 | 1 |
| Xeris Pharmaceuticals, Inc. | $19.98 | 1 |
| GlaxoSmithKline, LLC. | $15.94 | 1 |
| Corcept Therapeutics | $15.81 | 1 |
| Amgen Inc. | $14.73 | 1 |
| Acerta Pharma LLC | $14.04 | 1 |
| Phathom Pharmaceuticals, Inc. | $13.83 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $14.73 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117325857 | CMS |
| Astellas Pharma US Inc | $18.01 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139535720 | CMS |
| Astellas Pharma US Inc | $16.27 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139548853 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.04 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104781734 | CMS |
| Corcept Therapeutics | $15.81 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117730932 | CMS |
| GlaxoSmithKline, LLC. | $15.94 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115871575 | CMS |
| Lilly USA, LLC | $14.88 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135978538 | CMS |
| Lilly USA, LLC | $13.38 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135978630 | CMS |
| Lilly USA, LLC | $19.70 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135963726 | CMS |
| Merck Sharp & Dohme LLC | $23.98 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141607993 | CMS |
| Merck Sharp & Dohme LLC | $19.31 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141607991 | CMS |
| Novo Nordisk Inc | $12.76 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100261509 | CMS |
| Novo Nordisk Inc | $14.79 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100625486 | CMS |
| Novo Nordisk Inc | $10.07 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100379407 | CMS |
| Novo Nordisk Inc | $15.23 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100283380 | CMS |
| Novo Nordisk Inc | $12.66 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100246403 | CMS |
| Novo Nordisk Inc | $13.82 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100301781 | CMS |
| Novo Nordisk Inc | $15.32 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100653485 | CMS |
| Novo Nordisk Inc | $13.61 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100304287 | CMS |
| Novo Nordisk Inc | $10.32 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100358758 | CMS |
| Novo Nordisk Inc | $21.66 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100244277 | CMS |
| PFIZER INC. | $13.36 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131146757 | CMS |
| PFIZER INC. | $15.69 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131176596 | CMS |
| PFIZER INC. | $13.12 | 02/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131310339 | CMS |
| PFIZER INC. | $16.11 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131230732 | CMS |
| PFIZER INC. | $11.68 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131992415 | CMS |
| PFIZER INC. | $13.93 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131370369 | CMS |
| PFIZER INC. | $17.09 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131454768 | CMS |
| PFIZER INC. | $14.55 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131782720 | CMS |
| PFIZER INC. | $11.10 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131985789 | CMS |
| PFIZER INC. | $19.01 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131973393 | CMS |
| PFIZER INC. | $14.09 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132128538 | CMS |
| PFIZER INC. | $11.97 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131245023 | CMS |
| Phathom Pharmaceuticals, Inc. | $13.83 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151188618 | CMS |
| SANOFI-AVENTIS U.S. LLC | $21.28 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139764648 | CMS |
| Xeris Pharmaceuticals, Inc. | $19.98 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144639790 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.